These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6231750)
1. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain. Vallera DA; Quinones RR; Azemove SM; Soderling CC Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750 [TBL] [Abstract][Full Text] [Related]
2. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow. Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676 [TBL] [Abstract][Full Text] [Related]
3. Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies. Vallera DA; Ash RC; Zanjani ED; Kersey JH; LeBien TW; Beverley PC; Neville DM; Youle RJ Science; 1983 Nov; 222(4623):512-5. PubMed ID: 6353579 [TBL] [Abstract][Full Text] [Related]
4. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. Youle RJ; Neville DM Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914 [TBL] [Abstract][Full Text] [Related]
5. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin. Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971 [TBL] [Abstract][Full Text] [Related]
8. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation. Leonard JE; Taetle R; To D; Rhyner K Blood; 1985 May; 65(5):1149-57. PubMed ID: 3888307 [TBL] [Abstract][Full Text] [Related]
9. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates. Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447 [TBL] [Abstract][Full Text] [Related]
10. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin. Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246 [TBL] [Abstract][Full Text] [Related]
11. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Stong RC; Youle RJ; Vallera DA Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo perfusion of intestinal allografts with anti-T cell monoclonal antibody/ricin A chain conjugates for the suppression of graft-versus-host disease. Smith GJ; Ingham-Clark C; Crane P; Lear P; Wood RF; Fabre JW Transplantation; 1992 Apr; 53(4):717-22. PubMed ID: 1566334 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin. Vallera DA; Youle RJ; Neville DM; Kersey JH J Exp Med; 1982 Mar; 155(3):949-54. PubMed ID: 6120991 [TBL] [Abstract][Full Text] [Related]
14. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen. Youle RJ; Uckun FM; Vallera DA; Colombatti M J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613 [TBL] [Abstract][Full Text] [Related]
15. [Influences of an anti-pan-T cell ricin A-chain immunotoxin on generation of human immunocompetent T cells and hematopoietic progenitor cells]. Zhong W; Dai B Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):344-7. PubMed ID: 1839987 [TBL] [Abstract][Full Text] [Related]
16. Antigenic modulation by anti-CD5 immunotoxins. Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441 [TBL] [Abstract][Full Text] [Related]
17. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity. Pietersz GA; Kanellos J; McKenzie IF Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Raso V; Ritz J; Basala M; Schlossman SF Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605 [TBL] [Abstract][Full Text] [Related]
19. Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes; comparison of efficiency and specificity. Tonevitsky AG; Toptygin AYu ; Pfuller U; Bushueva TL; Ershova GV; Gelbin M; Pfuller K; Agapov II; Franz H Int J Immunopharmacol; 1991; 13(7):1037-41. PubMed ID: 1722193 [TBL] [Abstract][Full Text] [Related]
20. Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies. Vallera DA; Burns LJ; Frankel AE; Sicheneder AR; Gunther R; Gajl-Peczalska K; Pennell CA; Kersey JH J Immunol Methods; 1996 Oct; 197(1-2):69-83. PubMed ID: 8890895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]